Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 19
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Ramière, C. Roche, L. Scholtès, C. Iwaz, J. Saison, J. Ecochard, R. and André, P. 2016. Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994. Clinical Microbiology and Infection,

    Khetsuriani, Nino Tishkova, Faina Jabirov, Shamsidin Wannemuehler, Kathleen Kamili, Saleem Pirova, Zulfiya Mosina, Liudmila Gavrilin, Eugene Ursu, Pavel and Drobeniuc, Jan 2015. Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan. Vaccine, Vol. 33, Issue. 32, p. 4019.

    Komatsu, Haruki and Inui, Ayano 2015. Hepatitis B virus infection in children. Expert Review of Anti-infective Therapy, p. 1.

    Papastergiou, Vasilios Lombardi, Rosa MacDonald, Douglas and Tsochatzis, Emmanuel A. 2015. Global Epidemiology of Hepatitis B Virus (HBV) Infection. Current Hepatology Reports, Vol. 14, Issue. 3, p. 171.

    Tanase, Anna-Maria Marchio, Agnès Dumitrascu, Traian Dima, Simona Herlea, Vlad Oprisan, Gabriela Dejean, Anne Popescu, Irinel and Pineau, Pascal 2015. Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome. Journal of Exposure Science and Environmental Epidemiology, Vol. 25, Issue. 3, p. 256.

    Zhang, Weilu Ji, Zhaohua Wang, Ling Xiao, Dan and Yan, Yongping 2015. A meta-analysis of HBsAg-positive rate among general Chinese populations aged 1–-59 years. Infectious Diseases, Vol. 47, Issue. 12, p. 878.

    Conway, Richard Doran, Michele F. O’Shea, Finbar D. Crowley, Brendan and Cunnane, Gaye 2014. The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis. Clinical Rheumatology, Vol. 33, Issue. 12, p. 1823.

    Ozcirpici, Birgul Aydin, Neriman Coskun, Ferhat Tuzun, Hakan and Ozgur, Servet 2014. Vaccination coverage of children aged 12-23 months in Gaziantep, Turkey: comparative results of two studies carried out by lot quality technique: what changed after family medicine?. BMC Public Health, Vol. 14, Issue. 1,

    Tanase, Anna-Maria Dumitrascu, Traian Dima, Simona Grigorie, Razvan Marchio, Agnes Pineau, Pascal and Popescu, Irinel 2014. Influence of hepatitis viruses on clinico-pathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International, Vol. 13, Issue. 2, p. 162.

    Blachier, Martin Leleu, Henri Peck-Radosavljevic, Markus Valla, Dominique-Charles and Roudot-Thoraval, Françoise 2013. The burden of liver disease in Europe: A review of available epidemiological data. Journal of Hepatology, Vol. 58, Issue. 3, p. 593.

    Gheorghe, Liana Csiki, Irma E. Iacob, Speranta and Gheorghe, Cristian 2013. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania. European Journal of Gastroenterology & Hepatology, Vol. 25, Issue. 1, p. 56.

    Hahné, Susan JM Veldhuijzen, Irene K Wiessing, Lucas Lim, Tek-Ang Salminen, Mika and Laar, Marita van de 2013. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infectious Diseases, Vol. 13, Issue. 1,

    Schubert, Axel Michel, Detlef and Mertens, Thomas 2013. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation. BMC Infectious Diseases, Vol. 13, Issue. 1,

    HAHNÉ, S. J. M. DE MELKER, H. E. KRETZSCHMAR, M. MOLLEMA, L. VAN DER KLIS, F. R. VAN DER SANDE, M. A. B. and BOOT, H. J. 2012. Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiology and Infection, Vol. 140, Issue. 08, p. 1469.

    Tramuto, Fabio Mazzucco, Walter Maida, Carmelo Massimo Affronti, Andrea Affronti, Mario Montalto, Giuseppe and Vitale, Francesco 2012. Serological Pattern of Hepatitis B, C, and HIV Infections Among Immigrants in Sicily: Epidemiological Aspects and Implication on Public Health. Journal of Community Health, Vol. 37, Issue. 3, p. 547.

    Zehender, Gianguglielmo Shkjezi, Renata Ebranati, Erika Gabanelli, Elena Abazaj, Zhani Tanzi, Elisabetta Kraja, Dhimiter Bino, Silva Ciccozzi, Massimo and Galli, Massimo 2012. Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infection, Genetics and Evolution, Vol. 12, Issue. 2, p. 291.

    Morisco, Filomena Castiglione, Fabiana Rispo, Antonio Stroffolini, Tommaso Vitale, Roberto Sansone, Stefano Granata, Rocco Orlando, Ambrogio Marmo, Riccardo Riegler, Gabriele Vecchi, Maurizio Biancone, Livia and Caporaso, Nicola 2011. Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease. Digestive and Liver Disease, Vol. 43, p. S40.

    Turnour, Caroline E. Cretikos, Michelle A. and Conaty, Stephen J. 2011. Prevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data. Australian and New Zealand Journal of Public Health, Vol. 35, Issue. 1, p. 22.

    Wiese-Posselt, M. Reiter, S. Gilsdorf, A. and Krause, G. 2009. Needs and obstacles of uniform immunisation schedules in the European Union. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 52, Issue. 11, p. 1099.


A comparison of hepatitis B seroepidemiology in ten European countries

  • A. NARDONE (a1), C. G. ANASTASSOPOULOU (a2), H. THEETEN (a3), B. KRIZ (a4), I. DAVIDKIN (a5), W. THIERFELDER (a6), D. O'FLANAGAN (a7), B. BRUZZONE (a8), J. MOSSONG (a9), H. J. BOOT (a10), D. BUTUR (a11), M. SLAČIKOVÁ (a12), M. L. C. PANAIT (a11), W. HELLENBRAND (a6), H. DE MELKER (a10), Z. SOBOTOVÁ (a12), G. ICARDI (a8), N. ANDREWS (a1), R. G. PEBODY (a1), P. VAN DAMME (a3), G. KAFATOS (a1), E. MILLER (a1) and A. HATZAKIS (a2)
  • DOI:
  • Published online: 23 December 2008

To inform current and future vaccination strategies, we describe the seroepidemiology of hepatitis B virus (HBV) infection in ten representative European countries using standardized serology that allowed international comparisons. Between 1996 and 2003, national serum banks were compiled by collecting residual sera or by community sampling; sera were then tested by each country using its preferred enzyme immunoassays and testing algorithm, and assay results were standardized. Information on current and past HBV vaccination programmes in each country was also collected. Of the ten countries, six reported low levels (<3%) of antibodies against HBV core antigen (anti-HBc). Of the eight countries testing for HBV surface antigen (HBsAg), the highest prevalence was reported in Romania (5·6%) and in the remaining seven countries prevalence was <1%. Universal HBV vaccination programmes had been established in seven countries as recommended by the World Health Organization, but the seroprevalence of antibodies against HBsAg (anti-HBs) was lower than the reported vaccine coverage in three countries. Regular serological surveys to ascertain HBV status within a population, such as reported here, provide important data to assess the need for and to evaluate universal HBV vaccination programmes.

Corresponding author
*Author for correspondence: Dr A. Nardone, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, LondonNW9 5EQ, UK. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1.A Valsamakis . Molecular testing in the diagnosis and management of chronic hepatitis B. Clinical Microbiology Reviews 2007; 20: 426439.

2.C Roure . Overview of epidemiology and disease burden of hepatitis B in the European region. Vaccine 1995; 13: S1821.

4.P van Damme , A Vorsters . Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001. Journal of Medical Virology 2002; 67: 433439.

7.P van Damme , Introducing universal hepatitis B vaccination in Europe: differences still remain between countries. Eurosurveillance 2004; 9: 6768.

8.PP Mortimer , E Miller . Commentary: antenatal screening and targeting should be sufficient in some countries. British Medical Journal 1997; 314: 10361037.

9.T O'Connell , Prevalence of hepatitis B anti-core antibody in the Republic of Ireland. Epidemiology and Infection 2000; 125: 701704.

10.RG Pebody , Changing epidemiology of hepatitis B infection in Finland. Scandinavian Journal of Infectious Diseases 1999; 31: 251254.

11.S Hahne , Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy. Journal of Clinical Virology 2004; 29: 211220.

14.G Kafatos , The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus. Journal of Viral Hepatology 2007; 14: 260268.

15.NJ Andrews , The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiology and Infection 2000; 125: 127141.

16.G Kafatos , N Andrews , A Nardone . Model selection methodology for inter-laboratory standardisation of antibody titres. Vaccine 2005; 23: 50225027.

17. A Dominguez , Changes in the sero-epidemiology of hepatitis B infection in Catalonia, 1989–1996. Vaccine 2000; 18: 23452350.

18.G Da Villa , Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007; 25: 31333136.

19. W Jilg , M Schmidt , F Deinhardt . Vaccination against hepatitis B: comparison of three different vaccination schedules. Journal of Infectious Diseases 1989; 160: 766769.

20.M Gesemann , N Scheiermann . Hepatitis B vaccine boosting among young healthy adults. Lancet 1995; 345: 395396.

21.DJ West , GB Calandra . Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996; 14: 10191027.

22.JE Banatvala , P Van Damme . Hepatitis B vaccine – do we need boosters? J Viral Hepatology 2003; 10: 16.

23.European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000; 355: 561565.

25.D FitzSimons , Prevention and control of viral hepatitis through adolescent health programmes in Europe. Vaccine 2007; 25: 86518659.

26.A Mele , T Stroffolini , AR Zanetti . Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. Journal of Medical Virology 2002; 67: 440443.

27.J Zuckerman , B Langer . Hepatitis B vaccination in a school age population: a feasibility study. Journal of Medical Virology 2005; 75: 4754.

28.J Zuckerman , Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe? Lancet Infectious Diseases 2007; 7: 410419.

30.J Banatvala , P Van Damme , N Emiroglu . Hepatitis B immunisation in Britain: time to change? British Medical Journal 2006; 332: 804805.

31.W Thierfelder , Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. European Journal of Epidemiology 2001; 17: 429435.

32.RT Gandhi , Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. Journal of Infectious Diseases 2005; 191: 14351441.

33.N Qirbi , AJ Hall . Epidemiology of hepatitis B virus infection in the Middle East. Eastern Mediterranean Health Journal 2001; 7: 10341045.

34. H Kelly , A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002; 20: 31303136.

35.A Nardone , The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 78667872.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *